|
|
|
|
Fifteen patients with chronic inflammatory demyelinating neuropathy (CIDP) were treated with pulse intravenous cyclophosphamide (IVCY) monthly for up to 6 months. Eleven patients reached a complete remission; only one patient worsened. Complications included nausea, vomiting, anemia and hair loss. This case series suggests that monthly IVCY is beneficial in the treatment of CIDP and warrants a controlled study. |
|